Nom du produit:2,7-diethyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrazolo[1,5-b][1,2,4]triazole

IUPAC Name:5-[4'-({2,7-diethyl-5H-pyrazolo[1,5-b][1,2,4]triazol-5-yl}methyl)-[1,1'-biphenyl]-2-yl]-2H-1,2,3,4-tetrazole

CAS:151406-07-4
Formule moléculaire:C22H22N8
Pureté:95%+
Numéro de catalogue:CM1019370
Poids moléculaire:398.47

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:151406-07-4
Formule moléculaire:C22H22N8
Point de fusion:-
Code SMILES:CCC1=CN(N2C1=NC(=N2)CC)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
Densité:
Numéro de catalogue:CM1019370
Poids moléculaire:398.47
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
Tetrazoles
Tetrazoles are doubly unsaturated five-membered aromatic heterocycles consisting of one carbon atom and four nitrogen atoms. Tetrazole derivatives are a major class of heterocyclic compounds that are important for medicinal chemistry and drug design because of their not only isosteric properties with carboxylic acid and amide moieties, but also metabolic stability and other beneficial physicochemical properties.